Background: Immune thrombocytopenia is an acquired thrombocytopenia caused by autoantibodies against platelet antigens. Immune thrombocytopenia is usually observed more common in famale. Many patients with Immune thrombocytopenia are asymptomatic. Those with symptoms are primaril...
Aim: Platelet additive solutions (PAS) platelet collection methods, in which less donor plasma is used, are becoming more common in order to reduce the reactions occurring in patients. In our study, we aimed to evaluate the platelet quality in apheresis platelet suspensions (I) c...
COVID-19 is a viral infectious disease that is thought to have emerged from an animal market in Wuhan, People's Republic of China, in December 2019, and subsequently caused a pandemic. Despite the fact that one year has passed since the onset of the epidemic and many treatment ag...
Introduction: Thrombocytopenia is the situation where the number of thrombocytes is less than 150.000/ µL. This may result due to decreased thrombocyte production, increase in the destruction of thrombocytes and differentiation in distribution of thrombocytes. Hereditary and acqu...
Open access
Research Article10.9734/BJMMR/2014/4606
Aims: Decitabine is a drug for the treatment of myelodysplastic syndromes and acute myeloid leukemia. It has a side-effect profile affecting many systems, including dermatologic side effects. Herein, we report a case with a maculopapular-type drug eruption due to decitabine. Pres...
Open access
Research Article10.9734/BJMMR/2014/6347
Aims: Our study was undertaken to examine the laboratory and clinical features of pernicious anemia patients presenting initially at the Turgut Ozal Medical Center, which serves as an important tertiary health center in Eastern Anatolia. Study Design: Among patients evaluated for...
Open access
Research Article10.9734/BJMMR/2014/6147